Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Usher syndrome type 2A (USH2A) pre-messenger RNA exon 13 region is a critical segment of the USH2A transcript that encodes a portion of the usherin protein. Usherin is a large basement membrane-like protein located in the connecting cilia of photoreceptors and the hair cell bundle of the inner ear, where it is vital for structural integrity and sensory function (UniProt: O75445). Mutations in exon 13, most notably the c.2299delG frameshift mutation, are among the most frequent causes of Usher syndrome type 2A and autosomal recessive retinitis pigmentosa (NCBI Gene: 7399). This specific RNA region is targeted by antisense oligonucleotides (ASOs) like ulrevorsen (QR-421a) to modulate the splicing process. These therapeutic agents bind to the pre-mRNA and mask the splice sites of exon 13, causing the cellular machinery to skip this exon (Dulla et al., 2021, Molecular Therapy - Nucleic Acids). Because exon 13 contains an even number of nucleotides, its removal maintains the reading frame, leading to the production of a shortened but functional usherin protein that can mitigate the degenerative effects of the disease.
Antisense oligonucleotide-mediated exon skipping to exclude the mutation-bearing exon 13 from the mature mRNA, restoring the reading frame and producing a functional truncated usherin protein.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Usher syndrome type 2A pre-messenger RNA exon 13 region (USH2A pre-mRNA exon 13) (USH2A pre-mRNA exon 13).